home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Potential Drug For Atherosclerosis And Type 2 Diabetes

  June, 14 2007 19:52
your information resource in human molecular genetics
A small-molecule inhibitor that has been successfully tested in mice may prove useful against chronic metabolic diseases such as atherosclerosis, obesity and type 2 diabetes, a Nature paper published online suggests.

Gokhan S. Hotamisligil and colleagues treated genetic mice models of various metabolic diseases with a drug that inhibits a protein called aP2. When given orally, the drug molecule reduced the size of atherosclerotic lesions in blood vessels. It also decreased blood glucose levels and increased insulin sensitivity in a model of obesity and insulin resistance.

aP2 is expressed in fat cells and scavenging white blood cells called macrophages, where it mediates metabolic and inflammatory reactions. It's already known that mice genetically manipulated to lack the protein are protected against various aspects of metabolic disease, suggesting that aP2 may prove a useful drug target for these conditions. This study backs this idea up, hinting that aP2 inhibitors may aid the treatment of human cardiovascular disease and diabetes.


Gokhan S. Hotamisligil (Harvard School of Public Health, Boston, MA, USA)
E-mail: ghotamis@hsph.harvard.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.